Procedures of Locoregional Analgesia and Quality of Life in Palliative Care Units
TALViSoP
1 other identifier
interventional
38
1 country
6
Brief Summary
Number of patients in mobile palliative care units have pain of both nociceptive and neuropathic origin. In certain cases, procedures of locoregional analgesia can be helpful. The Purpose of this study is to evaluate the impact of techniques of locoregional analgesia in a palliative population
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable pain
Started Apr 2010
Longer than P75 for not_applicable pain
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2010
CompletedFirst Posted
Study publicly available on registry
March 29, 2010
CompletedStudy Start
First participant enrolled
April 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedSeptember 1, 2015
March 1, 2015
5.5 years
March 26, 2010
August 31, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in patients global quality of life
To evaluate the change in patients global quality of life, assessed by the item 15 of the validated quality of life scale EORTC QLQ-C15 PAL. Evaluations will take place before the procedure of locoregional analgesia and 1 week after.
1 week after first injection
Secondary Outcomes (1)
change in patient's global quality of life
2 days and 1 week after procedure
Interventions
Eligibility Criteria
You may qualify if:
- Patient ≥ 18 years-old, male or female, whatever his/her ethnic group
- Patient with untreatable cancer
- Patient hospitalized in a palliative care unit, with a life expectancy ≥ 1 week
- Pain unresponsive to conventional treatments
- Effectiveness of the injection test
- Signed informed consent
You may not qualify if:
- Patients \> 18 years-old
- Patients with pain other than cancer pain
- Patient's refusal
- Coagulation disorders
- Local infection
- Known hypersensitivity to local analgesics
- Inefficacy of the injection test.
- Contraindication for analgesics
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Centre Hospitalier Universitaire - Hôpital Saint André
Bordeaux, France
Centre Hospitalier de Châteauroux
Châteauroux, France
Centre Hospitalier de Guéret
Guéret, France
CHU Limoges
Liomges, France
Centre Hospitalier Local
Saint-Léonard-de-Noblat, France
Centre Hospitalier de Tulle
Tulle, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gérard TERRIER, MD
CHU Limoges
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2010
First Posted
March 29, 2010
Study Start
April 1, 2010
Primary Completion
October 1, 2015
Study Completion
October 1, 2015
Last Updated
September 1, 2015
Record last verified: 2015-03